M&A

News

Novartis buys neurology biotech AveXis for $8.7bn

Novartis has bought biotech AveXis for $8.7 billion, adding a potential gene therapy for the rare disease spinal muscular atrophy (SMA) to its pipeline.

News

Analysts question Takeda's bid for 'building site' pharma Sh...

Takeda has raised eyebrows after announcing its intention to bid for UK pharma Shire, with analysts suggesting the Japanese pharma will have to overpay to clinch the deal.

News

Shire surges as Takeda weighs takeover bid

Shares in the UK-based Shire Pharma have surged upwards after Takeda has disclosed that it is considering a takeover bid.

News

GSK to pay $13bn for Novartis stake in OTC joint venture

GlaxoSmithKline is to buy out Novartis from their over-the-counter joint venture, and may sell its Horlicks business to fund the £9.2 billion ($13bn) acquisition.

News